🔴 HCW Biologics is trading 14.97% down today; no verified catalyst identified

HCW Biologics is trading 14.97% down now at $2.50 after no verified September 8, 2026 company-specific catalyst was identified.

• The latest confirmed announcement was a September 2, 2026 USPTO patent allowance covering HCW9302 as an alopecia areata treatment.
• The announcement does not directly explain the current decline; broader markets are mixed, with the Dow down 0.81%, so the specific reason remains unclear.